USPTO serial 90056968
IMMUNITY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ADEMI, XHENETA
- Law office
- TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with IMMUNITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David G. Oberdick
DAVID G. OBERDICK MEYER, UNKOVIC & SCOTT LLP535 SMITHFIELD STREETSUITE 1300PITTSBURGH, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of immunological, viral, inflammatory, infectious autoimmune disorders; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations and substances, used internally as liquid medicines syrup, emulsion or suspension or solids as pills or capsules or chewable tablets for the treatment and prevention of viral infections by boosting the immune system to kill viruses, bacteria, coronaviruses including COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the prevention of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations, namely, elixirs for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical products for treating respiratory diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for COVID-19 (SARS-COV-2) and coronavirus; Inhaled pharmaceutical preparations for the treatment of COVID-19 or coronavirus respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations to boost, enhance, induce, or train and educate the immune system for the treatment of COVID-19 disease and immune system related diseases and disorders Dietary and nutritional supplements for therapeutic treatment to boost immune system responses against COVID-19 disease and immune related diseases and disorders; Dietary and nutritional supplements for boosting immune system responses; Pharmaceuticals, namely, immunomodulators, antivirals, antibiotics and anti-inflammatories | ACTIVE | — |
| 044 | Dispensing of pharmaceuticals; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; pharmaceutical advice | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 13, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 13, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 30, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 13, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 20, 2020 | NWAP | NEW APPLICATION ENTERED | — |